# Gerard Hascoet

> Gerard Hascoet is a Series A investor at MD Start (Paris) backing Health Care and Medical Device. See 4 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [MD Start](https://shizune.co/investors/profile/md-start)
- Location: Paris, France
- Total investments: 4
- Last investment: Apr 2022
- Lead investor: 25%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/gerard-hasco%C3%ABt-79a30695

Gerard Hascoet is a Series A investor at MD Start in Paris focused on Health Care and Medical Device. Gerard Hascoet is the Executive Chairman of MD Start.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 2 | 50% |
| Medical Device | 2 | 50% |
| Manufacturing | 1 | 25% |
| Emergency Medicine | 1 | 25% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 1 | 25% |
| Series B | 1 | 25% |
| Series C | 1 | 25% |
| Series D | 1 | 25% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| LimFlow SA | LimFlow System is approved for sale in markets regulated by the CE Mark. Investigational device in the United States. Limited by U.S. federal law to investigational use only in the U.S. LimFlow is a game-changing technology that enables clinicians to bring new hope to end-stage chronic limb ischemia (CLI) patients, when all other revascularizationefforts have been exhausted. By restoring perfusion to the ischemic foot through a completely novel, percutaneous procedure, the LimFlow System can relieve ischemic pain, promote wound healing, reduce amputations and restore mobility for patients when used as part of a multi-disciplinary team approach. | $39.3M | Series D | Apr 05, 2022 |  |
| Corwave | The CorWave LVAD utilizes an undulating disc wave pumping mechanism, replacing the high speed, high shear impeller of current continuous flow rotary pumps. The result is much less trauma to the blood, reducing clotting and bleeding complications. The high frequency actuation of the Corwave pump provides for pulsatile flow that mimics the action ofthe native heart. Current LVADs provide only continuous flow with no significant pulsation, due to the high inertia of their rotors. Its low power consumption and small size will facilitate totally implantablity with the incorporation of a wireless energy transfer system. | $43.2M | Series C | Jan 06, 2021 |  |
| Corwave | The CorWave LVAD utilizes an undulating disc wave pumping mechanism, replacing the high speed, high shear impeller of current continuous flow rotary pumps. The result is much less trauma to the blood, reducing clotting and bleeding complications. The high frequency actuation of the Corwave pump provides for pulsatile flow that mimics the action ofthe native heart. Current LVADs provide only continuous flow with no significant pulsation, due to the high inertia of their rotors. Its low power consumption and small size will facilitate totally implantablity with the incorporation of a wireless energy transfer system. | $17.1M | Series B | Nov 04, 2016 |  |
| Corwave | The CorWave LVAD utilizes an undulating disc wave pumping mechanism, replacing the high speed, high shear impeller of current continuous flow rotary pumps. The result is much less trauma to the blood, reducing clotting and bleeding complications. The high frequency actuation of the Corwave pump provides for pulsatile flow that mimics the action ofthe native heart. Current LVADs provide only continuous flow with no significant pulsation, due to the high inertia of their rotors. Its low power consumption and small size will facilitate totally implantablity with the incorporation of a wireless energy transfer system. | $3.5M | Series A | Jul 10, 2013 |  |

4 of 4 investments shown.

## Co-investors
- [Bpifrance](https://shizune.co/investors/profile/bpifrance) — VC Fund, 3 deals together
- [Novo Holdings](https://shizune.co/investors/profile/novo-a-s) — VC Fund, 2 deals together
- [Seventure Partners](https://shizune.co/investors/profile/seventure-partners) — VC Fund, 2 deals together
- [Ysios Capital](https://shizune.co/investors/profile/ysios-capital) — VC Fund, 2 deals together
- [Arbevel](https://shizune.co/investors/profile/arbevel) — VC Fund, 1 deal together
- [Balestier](https://shizune.co/investors/profile/balestier) — VC Fund, 1 deal together

## About MD Start

VC Fund · Paris, France

MD Start is an incubator and fund dedicated to medical technologies. MD Start creates, develops, and operates medical projects, turning them into new companies with both strategic and hands-on approaches, in order to bring them to investment stage and commercial development.

3 contacts available at MD Start.

| Name | Title | Profile |
| --- | --- | --- |
| Gerard Hascoet | Executive Chairman | https://shizune.co/investors/profile/grard-hascot |
| Anne Osdoit | Partner | https://shizune.co/investors/profile/anne-osdoit |
| Tim Lenihan | Partner / Entrepreneur In Residence | https://shizune.co/investors/profile/tim-lenihan |

## Similar investors

### Similar industry
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [Bpifrance](https://shizune.co/investors/profile/bpifrance) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

### Similar country
- [Bpifrance](https://shizune.co/investors/profile/bpifrance) — VC Fund
- [Kima Ventures](https://shizune.co/investors/profile/kima-ventures) — VC Fund
- [Motier Ventures](https://shizune.co/investors/profile/motier-ventures) — VC Fund

## Featured in investor lists
- [Medical Device Angel Investors in France](https://shizune.co/investors/medical-device-angel-investors-france)
- [Manufacturing Angel Investors in France](https://shizune.co/investors/manufacturing-angel-investors-france)
- [Climate Angel Investors in France](https://shizune.co/investors/climate-angel-investors-france)

## FAQ

### What does Gerard Hascoet invest in?

Gerard Hascoet invests primarily in Health Care, Medical Device and Manufacturing startups, most often at Series A and Series B stage. Most of the 4 investments tracked by Shizune back companies in France. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Gerard Hascoet last invest?

The most recent investment recorded for Gerard Hascoet closed in Apr 2022. Shizune tracks 4 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co